Institute of Special Animal and Plant Sciences, Chinese Academy of Agricultural Sciences, Changchun 130112, China.
Jilin Business and Technology College, Changchun 130507, China.
J Virol Methods. 2024 Apr;325:114883. doi: 10.1016/j.jviromet.2024.114883. Epub 2024 Jan 7.
This study aims to establish a screening method for canine distemper virus (CDV) microneutralizing activity suitable for microvolume samples.
This method is based on the Indirect immunofluorescence assay (IFA) established on Vero-slam cells. First, by comparing the sensitivities of CDV neutralizing monoclonal antibody (1C42H11) and NP protein monoclonal antibody (CDV-NP) in IFA experiments, CDV-NP was selected as the primary antibody. Then, by detecting the infection rates of multi-concentrations of CDV neutralized with water, the minimum CDV concentration with an infection rate greater than 90% was defined as the minimum stable infection concentration, which was used as the neutralizing solution for this method. Finally, the CDV-positive neutralizing serum (neutralizing titer 1:708) was diluted into multiple dilution groups as test samples, and then neutralized in equal volumes with the neutralizing solution to detect the neutralizing activity detection rates of each dilution group and the lowest detection limit of this method.
The results showed that the neutralizing activity of serum with a CDV neutralizing titer of 1:708 diluted 2 times was the lowest limit of detection, and the detection rate of microneutralizing activity was 63.54 ± 4.774%.
This study established an economical, stable, and easy-to-operate CDV microneutralizing activity high-throughput screening method, laying a methodological foundation for the development of native CDV neutralizing antibodies based on single B cells.
本研究旨在建立一种适用于微体积样本的犬瘟热病毒(CDV)微量中和活性的筛选方法。
该方法基于在 Vero-slam 细胞上建立的间接免疫荧光测定法(IFA)。首先,通过比较 CDV 中和单克隆抗体(1C42H11)和 NP 蛋白单克隆抗体(CDV-NP)在 IFA 实验中的敏感性,选择 CDV-NP 作为初级抗体。然后,通过检测用去离子水中和的多浓度 CDV 的感染率,定义感染率大于 90%的最小 CDV 浓度为最小稳定感染浓度,作为该方法的中和溶液。最后,将 CDV 阳性中和血清(中和效价 1:708)稀释为多个稀释组作为测试样本,然后与中和溶液等体积中和,检测每个稀释组的中和活性检测率和该方法的最低检测限。
结果表明,CDV 中和效价为 1:708 的血清稀释 2 倍的中和活性最低,微量中和活性的检测率为 63.54±4.774%。
本研究建立了一种经济、稳定、易于操作的 CDV 微量中和活性高通量筛选方法,为基于单个 B 细胞的天然 CDV 中和抗体的开发奠定了方法学基础。